160 related articles for article (PubMed ID: 7522717)
1. Biphenotypic M0 acute myeloid leukemia with trisomy-4.
Keung YK; Kaplan B; Douer D
Leuk Lymphoma; 1994 Jun; 14(1-2):181-4. PubMed ID: 7522717
[TBL] [Abstract][Full Text] [Related]
2. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
[TBL] [Abstract][Full Text] [Related]
3. Trisomy 4 as the sole karyotypic anomaly in acute biphenotypic leukemia with B lineage markers and in acute minimally differentiated myeloid leukemia (M0).
Cox-Froncillo MC; Zollino M; Del Poeta G; Bajer J; Stasi R; Venditti A; Tribalto M; Neri G; Papa G
Cancer Genet Cytogenet; 1995 Mar; 80(1):66-7. PubMed ID: 7697636
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
6. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
7. Association of GP40/CD7+ acute myeloblastic leukemia and chromosome 5 aberrations.
Lutz D; Kasparu H; Nowotny H; Weber E; Krieger O; Köller U; Tüchler H; Knapp W
Haematol Blood Transfus; 1990; 33():141-4. PubMed ID: 1691128
[No Abstract] [Full Text] [Related]
8. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
[TBL] [Abstract][Full Text] [Related]
9. Trisomy 10 and acute myeloid leukemia.
Czepulkowski B; Powell AR; Pagliuca A; Mufti GJ
Cancer Genet Cytogenet; 2002 Apr; 134(1):81-3. PubMed ID: 11996802
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0.
Suzuki R; Murata M; Kami M; Ohtake S; Asou N; Kodera Y; Tomonaga M; Masaki Y; Kusumoto S; Takeuchi J; Matsuda S; Hirai H; Yorimitsu mS; Hamajima N; Seto M; Shimoyama M; Ohno R; Morishima Y; Nakamura S
Int J Hematol; 2003 Jun; 77(5):482-9. PubMed ID: 12841387
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related CD7+ acute myeloid leukemia with trisomy 8 following acute monocytic leukemia.
Tanaka M; Kanamori H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
Anticancer Drugs; 2001 Sep; 12(8):681-2. PubMed ID: 11604555
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
[TBL] [Abstract][Full Text] [Related]
14. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.
Handa H; Motohashi S; Isozumi K; Komatsumoto S; Nara M
Acta Haematol; 2002; 108(1):47-52. PubMed ID: 12145468
[TBL] [Abstract][Full Text] [Related]
15. Peroxidase positive CD7+ myeloid leukaemia expressing only T lymphoid cell membrane markers: a new entity.
Philip PJ; Sudaka I; Baudouin F; Deville A; Bayle J
Br J Haematol; 1992 May; 81(1):138-9. PubMed ID: 1381607
[No Abstract] [Full Text] [Related]
16. Novel constitutional translocations t(3;5)(p25;q22) and t(1;14)(p31;q21) in patients with acute leukemia.
Panani AD; Pappa V; Raptis SA
Ann Hematol; 2004 Mar; 83(3):156-9. PubMed ID: 15064864
[TBL] [Abstract][Full Text] [Related]
17. Trisomy 10 in acute myeloid leukemia. Three additional cases from the database of the Japan Adult Leukemia Study Group (JALSG) AML-92 and AML-95.
Suzuki A; Kimura Y; Ohyashiki K; Kitano K; Kageyama S; Kasai M; Miyawaki S; Ohno R
Cancer Genet Cytogenet; 2000 Jul; 120(2):141-3. PubMed ID: 10942805
[TBL] [Abstract][Full Text] [Related]
18. Role of C-kit receptor in the diagnosis of leukemia: a relationship between expression of C-kit receptor and that of CD33 in leukemic blasts.
Muroi K; Amemiya Y; Miura Y; Nakamura M; Suda T
Leuk Res; 1993 Aug; 17(8):725-6. PubMed ID: 7689130
[No Abstract] [Full Text] [Related]
19. c-kit gene expression in CD7-positive acute lymphoblastic leukemia: close correlation with expression of myeloid-associated antigen CD13.
Nishii K; Kita K; Miwa H; Kawakami K; Nakase K; Masuya M; Morita N; Omay SB; Otsuji N; Fukumoto M
Leukemia; 1992 Jul; 6(7):662-8. PubMed ID: 1378163
[TBL] [Abstract][Full Text] [Related]
20. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia.
Miwa H; Kita K; Nishii K; Morita N; Takakura N; Ohishi K; Mahmud N; Kageyama S; Fukumoto M; Shirakawa S
Blood; 1993 Dec; 82(11):3445-51. PubMed ID: 7694687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]